Taylor et al. identified 21% of pediatric DIPG harbored heterozygous somatic coding mutations in the gene ACVR1, which encodes the activin A type I receptor serine/threonine kinase ALK2 (102). The gene discussed is MARK2; the disease is diffuse intrinsic pontine glioma.